NYU Researcher Warns US Dementia Diagnoses Will Reach 1 Million Annually by 2060

The United States healthcare system faces mounting pressure as demographic shifts drive a steep rise in dementia prevalence over the next quarter-century. This growth coincides with recent federal funding adjustments that have already tightened resources for long-term care providers.

A 2024 study published in Jama projects that annual dementia diagnoses in the US will increase from 514,000 in 2020 to 1 million by 2060. Globally, a new study in Jama Neurology estimates that new cases will rise from 11.4 million in 2023 to 24.7 million by 2050. Jordan Weiss, an assistant professor at the Optimal Aging Institute at NYU Langone, attributed this trajectory to increased life expectancy and the expanding Hispanic population, which nearly doubled between 2000 and 2024. The Alzheimer's Association notes that Hispanic individuals are 1.5 times as likely as white people to develop dementia.

The workforce capable of managing this patient population remains constrained. A 2024 report from the American Health Care Association found that nearly all nursing facilities struggled to recruit staff, with two-thirds citing a lack of qualified candidates as a primary obstacle. Approximately half of these facilities reported limiting new admissions due to these shortages. The Center for American Progress predicts that demand for nursing assistants will rise by 48% and for home health aides by 42% between 2020 and 2035. Despite this demand, the Bureau of Labor Statistics reported that median wages in May 2025 stood under $19 an hour for nursing assistants and $17 an hour for home health aides.

Specialized medical supply has also declined. A Jama report indicated that the number of geriatricians in the US dropped from 10,270 in 2000 to 7,413 in 2022. Weiss identified low compensation as a factor in this decrease. Regina Shih, a professor of epidemiology at Emory University, noted that retention among direct care workers is low because the work is difficult and cannot be replaced by artificial intelligence.

State governments have implemented various measures to address these gaps. According to a KFF survey, almost half of states offered incentive payments in 2025 to recruit or retain Medicaid home care workers. South Carolina established a loan forgiveness program for physicians who complete geriatrics or geriatric psychiatry fellowships and practice in the state for at least five years. However, the One Big Beautiful Bill Act, passed in 2025, introduced nearly $1 trillion in Medicaid cuts over 10 years. KFF reports that Medicaid funds more than half of US long-term care spending.

Medical advancements offer partial solutions but come with financial implications. The Food and Drug Administration has approved Kisunla and Leqembi, which can modestly slow cognitive decline in some patients with early Alzheimer's disease. Blood tests are also available to help diagnose the illness and predict risk. Julie Zissimopoulos, a University of Southern California professor, stated that while these advances may improve lives, they will be costly for the healthcare system.

Weiss urged a focus on preventive measures such as better cardiovascular health and physical activity to lower risk. He emphasized that building a system capable of delivering the care people already need is as important as waiting for future breakthroughs.